Gambaran Peresepan Obat pada Pasien Diabetes Mellitus di Puskesmas Karang Rejo Tarakan Periode April-Juni Tahun 2024

Monika Limbong; Syuhada Syuhada; Benazir  Evita Rukaya

doi:10.57174/j.born.v4i3.169

Authors

Monika Limbong Program Studi D-III Farmasi, Politeknik Kaltara Tarakan, Kalimantan Utara,77113, Indonesia
Syuhada Syuhada Program Studi D-III Farmasi, Politeknik Kaltara Tarakan, Kalimantan Utara,77113, Indonesia https://orcid.org/0000-0002-3756-1130
Benazir Evita Rukaya Program Studi D-III Farmasi, Politeknik Kaltara Tarakan, Kalimantan Utara,77113, Indonesia

DOI:

https://doi.org/10.57174/j.born.v4i3.169

Keywords:

drug prescription, diabetes mellitus, Health Center, pharmacotherapy

Abstract

Diabetes mellitus requires pharmacological therapy to control blood glucose levels and prevent complications. Evaluating drug prescribing patterns in Community Health Centers is crucial for assessing the suitability of therapy by clinical guidelines. Puskesmas is the primary healthcare facility that is easily accessible to the community, especially for common and chronic diseases, one of which is Diabetes mellitus. This study analyzed drug prescribing patterns in patients with diabetes mellitus at the Karang Rejo Community Health Center, Tarakan, including the number of drug items per prescription, the most frequently prescribed types of drugs, and the distribution of prescriptions based on pharmacological groups. This study employed a retrospective descriptive design with a total sampling method, utilizing medical record data from patients with diabetes mellitus. The analysis was carried out descriptively quantitatively using frequency and percentage distributions. The results showed that most patients were female (66%) with an average age of 57.89 years and a body weight of 60.69 kg. The average number of drug items per prescription was 3.29, with oral antidiabetics as the most frequently prescribed drug group (36.28%), followed by antihypertensives (16.45%) and neurotropic vitamins (13.28%). In addition, 15.07% of prescriptions contained ≥5 types of drugs, indicating polypharmacy that needs to be monitored to prevent drug interactions and side effects. The pattern of drug prescription at Karang Rejo Health Center is based on the therapeutic needs of patients with diabetes mellitus. However, routine monitoring is still needed to ensure the effectiveness and safety of therapy, especially for patients with polypharmacy.

Downloads

Download data is not yet available.

References

1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 16 Desember 2013;37(Supplement_1):S81–90.

2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice. 1 Desember 2011;94(3):311–21.

3. Zakir M, Ahuja N, Surksha MA, Sachdev R, Kalariya Y, Nasir M, dkk. Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways. Cureus. 15(9):e45835.

4. Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, dkk. Economic Costs of Diabetes in the U.S. in 2022. Diabetes Care. 1 November 2023;47(1):26–43.

5. Aloke C, Egwu CO, Aja PM, Obasi NA, Chukwu J, Akumadu BO, dkk. Current Advances in the Management of Diabetes Mellitus. Biomedicines. 29 September 2022;10(10):2436.

6. American Diabetes Association. Standards of Care in Diabetes—2023 Abridged for Primary Care Providers. Clinical Diabetes. 12 Desember 2022;41(1):4–31.

7. Katundu KGH, Mukhula V, Phiri T, Phiri C, Filisa-Kaphamtengo F, Chipewa P, dkk. High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, Malawi. BMC Cardiovascular Disorders. 22 Desember 2022;22(1):557.

8. Tiwari K, Bisht M, Kant R, Handu SS. Prescribing pattern of anti-diabetic drugs and adherence to the American Diabetes Association’s (ADA) 2021 treatment guidelines among patients of type 2 diabetes mellitus: A cross-sectional study. J Family Med Prim Care. Oktober 2022;11(10):6159–64.

9. Jha BK, Sherpa ML, Imran M, Mohammed Y, Jha LA, Paudel KR, dkk. Progress in Understanding Metabolic Syndrome and Knowledge of Its Complex Pathophysiology. Diabetology. Juni 2023;4(2):134–59.

10. Castro’ ’Marildes Luiza de. Diabetic dyslipidaemia: which drugs to use [Internet]. 2020 [dikutip 18 Maret 2025]. Tersedia pada: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-19/diabetic-dyslipidaemia-which-drugs-to-use

11. Puskesmas Fokus Wujudkan Masyarakat Hidup Sehat [Internet]. 2024 [dikutip 18 Maret 2025]. Tersedia pada: https://kemkes.go.id/id/puskesmas-fokus-wujudkan-masyarakat-hidup-sehat

12. Prospective, Retrospective, Case-control, Cohort Studies - StatsDirect [Internet]. 2025 [dikutip 18 Maret 2025]. Tersedia pada: https://www.statsdirect.com/help/basics/prospective.htm

13. Kotronoulas G, Miguel S, Dowling M, Fernández-Ortega P, Colomer-Lahiguera S, Bağçivan G, dkk. An Overview of the Fundamentals of Data Management, Analysis, and Interpretation in Quantitative Research. Seminars in Oncology Nursing. 1 April 2023;39(2):151398.

14. Heianza Y, Arase Y, Kodama S, Hsieh SD, Tsuji H, Saito K, dkk. Effect of Postmenopausal Status and Age at Menopause on Type 2 Diabetes and Prediabetes in Japanese Individuals: Toranomon Hospital Health Management Center Study 17 (TOPICS 17). Diabetes Care. Desember 2013;36(12):4007–14.

15. Mordarska K, Godziejewska-Zawada M. Diabetes in the elderly. Menopause Rev. 2017;16(2):38–43.

16. Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metabolism. 4 Januari 2022;34(1):11–20.

17. Varghese D, Ishida C, Patel P, Haseer Koya H. Polypharmacy. Dalam: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [dikutip 18 Maret 2025]. Tersedia pada: http://www.ncbi.nlm.nih.gov/books/NBK532953/

18. Koernaini T. Profil Peresepan Obat Anti Diabetes (Glimepiride) Di UPT Puskesmas Gedongan Kota Mojokerto Periode Oktober - Desember 2018 [Internet]. 2019 [dikutip 18 Maret 2025]. Tersedia pada: https://oasis.iik.ac.id:9443/repo/items/show/7258

19. Long AN, Dagogo-Jack S. Comorbidities of Diabetes and Hypertension: Mechanisms and Approach to Target Organ Protection. The Journal of Clinical Hypertension. 2011;13(4):244–51.

20. Beshyah SA, Jayyousi A, Al-Mamari AS, Shaaban A, Ozairi EA, Nafach J, dkk. Current Perspectives in Pre- and Diabetic Peripheral Neuropathy Diagnosis and Management: An Expert Statement for the Gulf Region. Diabetes Ther. 1 Desember 2024;15(12):2455–74.